市場調查報告書
商品編碼
1494386
歐洲生命徵象監測設備市場預測至 2030 年 - 區域分析 - 按產品和最終用戶Europe Vital Signs Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Product and End User |
2022年歐洲生命徵象監測設備市場價值為81.0112億美元,預計2030年將達222.8546億美元;預計2022年至2030年複合年成長率為13.5%。
即時通訊功能的整合推動了歐洲生命徵象監測設備市場
醫療保健中遠端存取的採用以及音訊和視訊技術的進步縮小了患者與獲得醫療保健服務之間的差距。因此,遠距醫療已獲得顯著普及,並為即時通訊(RTC)鋪平了道路。將 RTC 功能整合到生命徵象監測設備中,預計將使患者能夠根據自己的舒適度與醫療保健提供者有效地聯繫,以接受虛擬諮詢和基本醫療服務。
公司正在開發採用即時技術的產品,以有效監測患者的生命徵象。 2023 年 3 月,Vigilant Medical Solutions, LLC 宣布開發 Guardian 行動應用程式和醫療設備解決方案,當患者生命徵象發生即時變化時,該解決方案將透過智慧型手機向院內麻醉師發出警報。 Guardian 與人工智慧技術相結合,可提供術後譫妄、中風、急性腎損傷和死亡的重要最新資訊。 Vigilant Medical Solutions, LLC 聲稱,當醫生忙於在不同房間或手術室治療多名患者時,Guardian 的設計目的是讓患者輕鬆了解患者的生命徵象。 2021 年 10 月,霍尼韋爾推出即時健康監測系統 (RTHMS)。 RTHMS 是一個智慧邊緣到雲端通訊平台,旨在對患者進行遠端即時監控。這款針對護理人員的行動應用程式會在患者異常生命徵像出現任何偏差時向他們發出警報。該公司還聲稱,使用 RTHMS 將使醫院的管理任務減少 35%。在世界各地的醫療機構中採用和安裝此類創新技術將使醫療保健部門受益並提高患者的健康品質。
因此,即時通訊功能的整合可能會在未來幾年推動歐洲生命徵象監測設備市場的發展。
歐洲生命徵象監測設備市場概況
歐洲的生命徵象監測設備市場進一步細分為德國、英國、法國、西班牙、義大利和歐洲其他地區。該地區的市場成長取決於慢性病發病率上升、產品推出數量增加、產品開發投資增加以及人口老化激增等因素。
根據國家統計局2023年4月公佈的2021年人口普查資料,65歲及以上人口從2011年的920萬增加到2021年的1100萬。增加。因此,隨著人口老化的加劇,英國對先進生命徵象監測設備的需求正在增加。
此外,根據歐洲衛生系統和政策觀察站2020年發布的資料,德國每6人就有1人肥胖,總人口中近15%患有糖尿病。因此,國內對血糖監測儀的需求量大。此外,德國有 1-2 名 15 歲以上的人報告患有慢性病。此外,與糖尿病相關的醫療保健服務在法國也得到報銷。法國擁有參與研發、提供創新醫療器材技術的知名公司。 2020 年 10 月,法國公司 Zoook 開發並推出了非接觸式醫療級溫度計,以維持 COVID-19 大流行的規範。這些創新極大地促進了該國生命徵象監測設備市場的成長。
歐洲生命徵象監測設備市場收入及 2030 年預測(百萬美元)
歐洲生命徵象監測設備市場區隔
歐洲生命徵象監測設備市場根據產品、最終用戶和國家進行細分。
根據產品,歐洲生命徵象監測設備市場分為脈搏血氧儀、血壓監測儀、溫度監測設備和血糖監測設備。到 2022 年,血糖監測設備細分市場佔據最大佔有率。此外,脈搏血氧儀細分為手持式脈搏血氧儀、桌上型脈搏血氧儀和脈搏血氧儀配件。溫度監測設備分為數位溫度計、紅外線溫度計、水銀溫度計和液晶溫度計。此外,依血壓監測設備分類,市場分為數位血壓計、類比血壓計、動態血壓計、水銀血壓計和血壓儀配件。
依最終用戶分類,歐洲生命徵象監測設備市場分為醫院和診所、門診護理中心、家庭醫療保健等。 2022 年,醫院和診所領域佔最大佔有率。
根據國家/地區,歐洲生命徵象監測設備市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。 2022 年,德國在歐洲生命徵象監測設備市場佔據主導地位。
Koninklijke Philip NV、Medtronic Plc、Nihon Kohden、GE HealthCare Technologies Inc、OMRON corp、Masimo Corp、Nonin Medical Inc、Contec Medical Systems Co Ltd 和 Baxter Intonational Inc 是歐洲生命徵象監測設備市場的一些領先公司。
The Europe vital signs monitoring devices market was valued at US$ 8,101.12 million in 2022 and is expected to reach US$ 22,285.46 million by 2030; it is estimated to grow at a CAGR of 13.5% from 2022 to 2030.
Integration of Real-Time Communication Feature Fuels the Europe Vital Signs Monitoring Devices Market
The adoption of remote access in healthcare, and advancements in audio and video technologies have bridged the gap between patients and accessing healthcare services. Thus, telemedicine has gained noticeable popularity and has paved the way for real-time communication (RTC). The integration of the RTC feature in vital sign monitoring devices is expected to allow patients to connect with healthcare providers efficiently according to their comfort to receive virtual consultations and essential medical services.
Companies are developing products that incorporate real-time technologies to allow efficient monitoring of patients' vital signs. In March 2023, Vigilant Medical Solutions, LLC announced the development of the Guardian mobile app and medical device solution that would alert in-hospital anesthesiologists on their smartphones when there is a real-time change in patients' vitals. Guardian is incorporated with artificial intelligence technology that provides vital updates on postoperative delirium, stroke, acute kidney injury, and death. Vigilant Medical Solutions, LLC claims that Guardian is designed to provide easy access to patients' vitals when doctors are busy treating several patients in different rooms or operating rooms. In October 2021, Honeywell launched a Realtime Health Monitoring System (RTHMS). RTHMS is a smart edge-to-cloud communication platform intended for the remote and real-time monitoring of patients. This mobile app for caregivers alerts them after any deviation in a patient's abnormal vitals. The company has also claimed that using RTHMS would reduce hospital administrative tasks by 35%. Adopting and installing such innovative technologies in healthcare facilities worldwide would benefit the healthcare sector and enhance patient health quality.
Thus, the integration of real-time communication features is likely to propel the Europe vital signs monitoring devices market in the coming years.
Europe Vital Signs Monitoring Devices Market Overview
The vital signs monitoring devices market in Europe is further segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. The market growth in the region is determined by factors such as the rising incidences of chronic diseases, increasing number of product launches, growing investments for product developments, and a surge in the aging population.
According to the Census 2021 data published by the Office for National Statistics in April 2023, the population aged 65 and above rose to 11 million in 2021 from 9.2 million in 2011. The geriatric population is increasing with the upsurge in life expectancy and advancements in healthcare, which enhances the quality of life. Thus, demand for advanced vital signs monitoring devices in the UK is increasing with the growing aging population.
Furthermore, as per data published by the European Observatory on Health Systems and Policies in 2020, 1 out of 6 persons in Germany is obese, and nearly 15% of the total population is living with diabetes. Therefore, there is a vast demand for glucose monitors in the country. Moreover, 1-2 persons above age 15 in Germany report a chronic condition. Also, Healthcare services related to diabetes are also reimbursed in France. France has well-established companies involved in research and development, providing innovative medical device technologies. In October 2020, Zoook, a French company, developed and launched as a contactless medical-grade thermometer to maintain the norms of the COVID-19 pandemic. Such innovations contribute significantly to the vital signs monitoring devices market growth in the country.
Europe Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)
Europe Vital Signs Monitoring Devices Market Segmentation
The Europe vital signs monitoring devices market is segmented based on product, end user, and country.
Based on product, the Europe vital signs monitoring devices market is segmented into pulse oximeters, blood pressure monitors, temperature monitoring devices, and glucose monitors devices. The glucose monitors devices segment held the largest share in 2022. The glucose monitoring devices segment is further bifurcated into self glucose monitors and continuous glucose monitors. Additionally, the pulse oximeters segment is subsegmented into handheld pulse oximeters, table-top pulse oximeters, and pulse oximeter accessories. The temperature monitoring devices segment into digital thermometers, infrared thermometers, mercury filled thermometers, and liquid crystal thermometers. Further, by blood pressure monitoring devices, the market is categorized into digital blood pressure monitors, analog blood pressure monitors, ambulatory blood pressure monitors, mercury blood pressure monitors, and blood pressure instrument accessories.
By end user, the Europe vital signs monitoring devices market is segmented into hospitals & clinics, ambulatory care centers, home healthcare, and other. The hospitals & clinics segment held the largest share in 2022.
Based on country, the Europe vital signs monitoring devices market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe vital signs monitoring devices market in 2022.
Koninklijke Philip NV, Medtronic Plc, Nihon Kohden, GE HealthCare Technologies Inc, OMRON corp, Masimo Corp, Nonin Medical Inc, Contec Medical Systems Co Ltd, and Baxter Intonational Inc are some of the leading companies operating in the Europe vital signs monitoring devices market.